While time in the market generally beats out timing the market, it’s understandable that some investors may want to hold off on looking for stocks to buy. After all, equities continue to digest the sudden failure of a handful of financial institutions. The realization that archaic bank runs can happen in modern American society sent a chill down investors’ spines. Not everyone is taking a pessimistic view though. Rather surprisingly, legendary hedge fund manager Michael Burry recently tweeted that the quick action the U.S. government took to fend off a banking crisis contagion represented a game-changing stance. Earlier, Burry tweeted out that he saw little risk with the much-discussed bank runs. Acquiring stocks now may turn out to be a bold and lucrative decision. At some point, the pain will pass. Whether you want to dive in now or wait a bit, these are some of the top stocks to buy. ABC AmerisourceBergen $152.05 CAH Cardinal Health $70.51 VLO Valero Energy $127.17 ANDE Andersons $39.68 PFGC Performance Food Group $54.72 BNTX BioNTech $131.96 OPAD Offerpad Solutions $0.57 AmerisourceBergen (ABC) Source: shutterstock.com/Champhei First up on my list of stocks to buy before the market regains its mojo is AmerisourceBergen (NYSE: ABC ).

Cardinal Health is a leader in its industry and has had another stellar quarterly performance with revenues increasing 13%. Find out if CAH stock is a buy.

Cardinal Health (CAH) announces collaboration with Signify Health (SGFY) to offer in-home clinical and medication management services through its Outcomes business.This collaboration…

DUBLIN, Ohio , March 6, 2023 /PRNewswire/ -- Cardinal Health (NYSE: CAH ) today announced its collaboration with Signify Health (NYSE: SGFY ) to offer in-home clinical and medication management services through its Outcomes™ business. This collaboration will help reduce costs and eliminate gaps in care for more than 2.3 million members nationwide to support their treatment journey from prescription to pharmacy to home. … Full story available on Benzinga.com

Technical analysis for Cardinal Health CAH including support levels resistance levels and stop losses for CAH

Drug distributors Cardinal Health Inc, McKesson Corp and JM Smith Corp on Wednesday prevailed at trial in Georgia in a case brought by families of opioid addicts accusing the companies of acting as drug dealers. A jury in Glynn County Superior Court handed down the verdict after two days of deliberations, according to Courtroom View […]

NEWARK, DE / ACCESSWIRE / March 1, 2023 / The Surgical Drapes Market revenues were estimated at US$ 1.4 Billion in 2022 and is anticipated to grow at a CAGR of 4.2% from 2023 to 2033, according to a recently published Future Market Insights report. By the end of 2033, the market is expected to reach US$ 2.1 Billion. The market revenue through disposable surgical drapes is expected to grow at a CAGR of 4.8% from 2023 to 2033. An increase in the occurrence of chronic diseases around the world is a key factor driving the market forward. According to the American Heart Association, by 2035, more than 130 million people, or 45.1% of the adult population in the United States, could be suffering from some type of CVD. According to the Centers for Disease Control and Prevention, around 655,000 Americans die each year from heart disease, accounting for one out of every four deaths. Request Sample Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-16611 According to the CDC, 6 out of 10 persons in the United States suffer from a chronic disease, with 4 out of 10 having two or more chronic diseases.

Cardinal Health - Consensus Indicates Potential 10.7% Upside

In this article, we will take a look at the 12 high growth healthcare stocks to buy. To see more such companies, go directly to 5 High Growth Healthcare Stocks to Buy. The healthcare sector proved its mettle in 2022. When the broader stock market was in turmoil, major healthcare companies, including Cardinal Health, McKesson […]

Study reveals provider perceptions of commercially available biosimilars and anticipated launches, which have the potential to increase equitable access to critical treatments DUBLIN, Ohio, Feb. 22, 2023 /PRNewswire/ -- Today, Cardinal Health (NYSE: CAH) released its 2023 Biosimilars…

Cardinal Health''s consistent fundamentals and growth prospects was reinforced by Q2 2023 earnings. Click here for my take on CAH stock now.

Cardinal Health, Inc. - Consensus Indicates Potential 9.9% Upside

Cardinal Health (NYSE:CAH) declares $0.4957/share quarterly dividend, in line with previous.Forward yield 2.48%Payable April 15; for shareholders of record April 3; ex-div March 31.See CAH…

DUBLIN, Ohio, Feb. 10, 2023 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved a quarterly dividend of $0.4957 per share out of the Company''s capital surplus. The dividend will be payable on April 15, 2023 to shareholders of record at the…

https://www.investing.com/news/pro/cardinal-health-pt-raised-to-86-at-cowen-432SI-3000775

Related Stocks: NFLX , CAH , MDT , FIS , WBD ,

Related Stocks: CAH , PM , BIL , HON , WBD ,

https://www.investing.com/news/pro/cardinal-health-pt-raised-to-82-at-deutsche-bank-432SI-2996197

Monday''s top analyst upgrades and downgrades included Bill.com, Boeing, Cardinal Health, Cognizant Technology Solutions, ConocoPhillips, C3.ai, Enphase Energy, Ford, International Paper, Meta Platforms, Nordstrom, Spirit Aerosystems and Upstart.

Baird has upgraded Cardinal Health (CAH) to outperform from neutral after the drug wholesaler raised its 2023 profit guidance and its quarterly results beat on the top and bottom lines.

Cardinal Health (NYSE: CAH ) brought in sales totaling $51.47 billion during Q2 according to data provided by Benzinga Pro . However, earnings decreased 217.12%, resulting in a loss of $130.00 million. Cardinal Health reached earnings of $111.00 million and sales of $49.60 billion in Q1. What Is ROCE? Return on Capital Employed is a measure of yearly pre-tax profit relative to capital employed by a business. Changes in earnings and sales indicate shifts in a company''s ROCE. A higher ROCE is generally representative of successful growth of a company and … Full story available on Benzinga.com

https://www.investing.com/news/pro/baird-upgrades-cardinal-health-to-outperform-432SI-2994725

Cardinal Health, Inc. (NYSE:NYSE:CAH) Q2 2023 Earnings Conference Call February 2, 2023 8:30 AM ETCompany ParticipantsKevin Moran – Vice President-Investor RelationsJason Hollar – Chief…

Cardinal Health (CAH) on Thursday posted a better-than-expected second quarter and raised its 2023 profit guidance, helped by growth in pharmaceutical segment. The company now sees…

The following slide deck was published by Cardinal Health, Inc.

WASHINGTON (dpa-AFX) - (Adds Outlook)Below are the earnings highlights for Cardinal Health Inc (CAH):Earnings: -$130 million in Q2 vs. $49 million in the same period last year. EPS: -$0.50 in Q2 v…

WASHINGTON (dpa-AFX) - Below are the earnings highlights for Cardinal Health Inc (CAH):Earnings: -$130 million in Q2 vs. $49 million in the same period last year. EPS: -$0.50 in Q2 vs. $0.17 in th…

Cardinal Health press release (CAH): Q2 Non-GAAP EPS of $1.32 beats by $0.18.Revenue of $51.47B (+13.2% Y/Y) beats by $1.44B.Fiscal year 2023 non-GAAP EPS guidance raised to $5.20…

Cardinal Health (NYSE:CAH):

Other drug wholesalers are down after AmerisourceBergen (ABC), which is off 4% in Wednesday afternoon trading, released Q4 2022 earnings earlier in the day.

Cardinal Health (NYSE: CAH ) is set to give its latest quarterly earnings report on Thursday, 2023-02-02. Here''s what investors need to know before the announcement. Analysts estimate that Cardinal Health will report an earnings per share (EPS) of $1.14. Cardinal Health bulls will hope to hear the company announce they''ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the … Full story available on Benzinga.com

Cardinal Health (CAH) is scheduled to announce FQ2 earnings results on Thursday, February 2nd, before market open.The consensus EPS Estimate is $1.14 (-10.2% Y/Y) and the consensus…

Cardinal Health (CAH) announced a collaboration with the software company Palantir Technologies (PLTR) on Thursday to offer a data-driven supply chain solution. Read the full story here.

The platform will combine and analyze datasets for live purchasing decision support of pharmaceuticals DUBLIN, Ohio and DENVER , Jan. 26, 2023 /PRNewswire/ -- Cardinal Health (NYSE: CAH ) announced today that it has entered into a strategic collaboration with Palantir Technologies Inc. (Palantir) (NYSE: PLTR ), a leading builder of operating systems for the modern enterprise, to design a solution that will give health systems and hospitals dynamic purchase decision insights in order to quickly improve their bottom line. The Cardinal Health solution, which will be integrated into Foundry, Palantir''s industry-leading operating system, will deploy artificial intelligence (AI) and machine learning (ML) to bring together diagnosis and clinical data with real-time customer purchasing and consumption data for pharmaceutical products with … Full story available on Benzinga.com

Committed to becoming a more sustainable healthcare partner, the company makes meaningful progress in key ESG areas DUBLIN, Ohio, Jan. 25, 2023 /PRNewswire/ -- Today, Cardinal Health (NYSE: CAH) published its Fiscal 2022 Environmental, Social and Governance (ESG) Report, which…